Most Brands Get the Injury Stat Wrong. Here's What the 2026 Data Actually Says.

Most brands get the injury stat wrong, and the wrong version is the one that spreads. The real ACL re-injury number is 20%, not 70%. The market isn't growing because injuries are scary. It's growing because participation is at a record high. Here's what the SFIA 2025-2026 data actually says, and why the brands still quoting "70% re-injury" are the ones getting torn apart in the comments by every physio who reads their site.

Everyone wants the injury statistic.

Most brands get it wrong, and the wrong version is the one that spreads.

Here's what the data actually says. After ACL reconstruction, cumulative re-injury runs about 20% - 6% on the graft you just replaced, 8% on the other one. Thirty percent of those land within two years. Elite soccer tracks closer: 9% in the earliest window, up to 17.9%, settling near 16.4%.

Twenty percent doesn't sound like a market.

The Stat Everyone Quotes Is Wrong

The relative risk is the market. Once you've torn your ACL, you're 4.4 times more likely to tear it again. Calf strains, 9 times. Hamstrings, 2.7 times - and more than half of those come back within 25 days of returning.

Those relative risk numbers are the stat the industry should be quoting. They're true. They're specific. They survive the first physio who reads your page. And they tell the actual story: the second injury isn't a fluke, it's a probability shift, and the question is what you do about it.

The 70% number that gets pasted onto brand sites doesn't survive anything. It isn't supported by the published data. It isn't even close. And the moment it shows up on a product page, it gives a smart reader - a physio, an athletic trainer, a team's medical staff - the exact reason to dismiss everything else you've written.

The Number That Actually Changes Outcomes

But the number that actually changes outcomes isn't anatomy. It's paperwork.

One study followed 158 athletes. The 33% who returned to play without passing return-to-play criteria all re-injured. Every one. Only 10% of the ones who passed criteria did.

That's the real argument for protective equipment. Not "70% of people get hurt again" - that isn't true, and if you publish it, the first physio who reads your page will take your brand apart in the comments. The honest argument is that the gap between prepared and unprepared is enormous, and most people return to sport unprepared because nobody ever told them they had a choice.

Prepared means: passed return-to-play criteria. Warmed up under supervision. Wearing the right brace for the right joint at the right moment. Understood the relative risk going in. Unprepared means: none of that, plus a coach who needed them back on the field last week.

The category is built for the prepared half. The unprepared half is the market that doesn't know it's a market yet - and that's where the rest of this story goes.

Where the Market Is Actually Going

On who buys - you're right that athletes buy more of it today. The brands serving competitive players have deeper baskets and shorter cycles. Competitive athletes re-buy every season, every injury, every return-to-play.

But look at where participation is actually going.

Casual team sports participation hit 65.9 million Americans in 2025, up 9.6%. Core participation - the committed players, the academy kids - grew 2.9% to 26.4 million.

Here's the part that matters. Historically, growth in casual participation shows up in core participation two to three years later. That isn't a projection. It's the pattern that has already repeated.

Which means the hobbyist buying a fifteen-dollar wrist wrap today isn't your low-value customer. They're the amateur competitive cohort that doesn't exist as a purchase category yet.

The base is real too. 81.3% of Americans aged six and up took part in at least one tracked sport or fitness activity in the year to June 2026. Inactivity fell to 18.7%, the lowest on record. Team sports reached 92.3 million, up 7.6%, fifth straight year of growth. Hiking hit 57.7 million. Tennis added 9.3% in a single year.

Read that again. Eighty-one percent of Americans are doing something. Inactivity is at a record low. Team sports have grown five years in a row. Tennis is up 9.3% in a single twelve-month window. None of this is the population getting more scared of injuries. It's the population getting more active, more committed, and - two to three years downstream - more willing to spend on the gear that keeps them in the game.

Why "Cheapest" Loses and "Worth It" Wins

One honest caveat. The same SFIA data shows 30.2% of participants facing higher costs this year, and 26.9% saying cost already changed how they participate. Money is a genuine headwind for this category.

Which is exactly why "cheapest" is a losing strategy here and "worth it" is the winning one.

The brand that pitches "$5 wrist wrap, same as the big guys" is competing on the axis the consumer is most squeezed on. The brand that pitches "this is the wrist wrap that survives two seasons and lets you keep playing after the strain comes back" is competing on the axis the consumer actually cares about - getting back on the court, the field, the mat, the bike, without a second injury that takes them out for a year.

Prepared vs unprepared. Worth it vs cheapest. The argument lines up with the data, and the data lines up with where the market is going.

This category isn't growing because injuries are scary. It's growing because the number of people playing is at a record high, and the segment that buys protective gear most heavily hasn't fully shown up yet.

When it does, the brands that survived the physio in the comments - the ones quoting real numbers, the ones that built for return-to-play, the ones that priced for value rather than for the lowest SKU on Amazon - those are the brands the next cohort of customers is going to find first.

Frequently Asked Questions